Opendata, web and dolomites

SOLID SIGNED

Suppression of Organelle Defects in Human Disease

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 SOLID project word cloud

Explore the words cloud of the SOLID project. It provides you a very rough idea of what is the project "SOLID" about.

therapeutic    mapping    platform    mutagenesis    absent    genome    contain    organelle    mutations    hurdles    create    limited    impaired    cures    suppressors    amount    fashion    eukaryotic    alter    correct    query    defects    organisms    initial    drugging    alongside    functioning    yielding    human    diseases    disorders    combines    systematic    biological    frustrations    genetic    environmental    questions    cellular    suppressor    reveal    revealing    diversity    mitochondria    metabolic    fidelity    extensive    recessive    urgently    causative    interrogate    centric    surveys    model    stratification    mutation    captures    fitness    entirely    modules    machines    cell    point    uncover    until    departs    view    organelles    lacking    incurable    perturbed    relies    difficulty    etiological    suppression    biology    yeast    mainly    remove    first    perturbation    engineering    concerted    independent    possibilities    triggers    hundreds    paradigm    instead    exhaustive    strategies    disease    applicable    genetics    lysosomes    direct    time    gene    mutants    ultradeep    hidden    haploid    phenotypes    solid    uniquely    substantial    neurodegeneration    mostly    exemplified    function    genes    fixed    altogether    groundbreaking    malfunctioning   

Project "SOLID" data sheet

The following table provides information about the project.

Coordinator
LUDWIG-MAXIMILIANS-UNIVERSITAET MUENCHEN 

Organization address
address: GESCHWISTER SCHOLL PLATZ 1
city: MUENCHEN
postcode: 80539
website: www.uni-muenchen.de

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Germany [DE]
 Total cost 1˙498˙400 €
 EC max contribution 1˙498˙400 € (100%)
 Programme 1. H2020-EU.1.1. (EXCELLENT SCIENCE - European Research Council (ERC))
 Code Call ERC-2018-STG
 Funding Scheme ERC-STG
 Starting year 2019
 Duration (year-month-day) from 2019-07-01   to  2024-06-30

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    LUDWIG-MAXIMILIANS-UNIVERSITAET MUENCHEN DE (MUENCHEN) coordinator 1˙498˙400.00

Map

 Project objective

The goal of SOLID is the systematic mapping of genetic suppression for important organelles with impaired fidelity in human disease to uncover new strategies to correct the perturbed state. Functioning of the eukaryotic cell relies on the concerted activity of biological machines, defects in which can cause incurable human disease, including metabolic disorders and neurodegeneration. This is exemplified by malfunctioning mitochondria or lysosomes, for which (alongside environmental triggers) hundreds of causative genes have been identified, but cures are mostly lacking. This is mainly due to the difficulty of drugging loss-of-function mutations, which uniquely alter or entirely remove the gene product. Extensive studies in yeast and initial work in the human system show that cellular modules contain a substantial amount of hidden genetic suppression. Revealing suppressors of disease-defining features of organelle perturbation and targeting those instead of the query mutations, will address the frustrations of drugging an absent factor and etiological diversity. Until now, mutation-based genome-wide suppressor surveys were mostly limited to model organisms and phenotypes yielding growth defects, due to technical hurdles associated with recessive genetics in the human system. However, with the development of a groundbreaking new forward genetics platform that combines genome engineering, ultradeep haploid mutagenesis and direct stratification of fixed mutants, we can now, for the first time, interrogate genetic suppression of human organelle defects independent of cellular fitness. SOLID will also develop new technology to study organelle fidelity in an exhaustive fashion that departs from a gene-centric view point and captures complex phenotypes. Altogether, this will create a new paradigm of 'studying cell biology via genetics' widely applicable to many different biological questions, and reveal urgently needed novel therapeutic possibilities for incurable diseases.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "SOLID" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "SOLID" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.1.1.)

OAlipotherapy (2018)

Long-retention liposomic drug-delivery for intra-articular osteoarthritis therapy

Read More  

CHIPTRANSFORM (2018)

On-chip optical communication with transformation optics

Read More  

CellProbe (2019)

CellProbe: Microfluidic probe for simultaneous tagging and extraction of single cells

Read More